Pharmacokinetics, bioequivalence, and food effect assessment of enteric-coated aspirin tablets: a randomized, single-dose, four-period crossover study in Chinese healthy subjects
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04282-w ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Minwan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Affiliated Beijing Luhe Hospital of Capital Medical University, Beijing, 101149, P.R, China. Hauptthemen laut MEDLINE: Aspirin, Food-Drug Interactions, Platelet Aggregation Inhibitors. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
This study assessed the pharmacokinetics, bioequivalence, and food effect of two enteric-coated aspirin tablets (100 mg) in healthy Chinese subjects. Ninety subjects were enrolled and divided into fasted (n = 42) and fed cohorts (n = 48) in a single-center, randomized, open-label, single-dose, four-period, two-sequence and crossover study. The pharmacokinetic characteristics of acetylsalicylic acid (aspirin) and its metabolite salicylic acid, including Cmax and AUC, were compared after subjects received single oral doses of enteric-coated aspirin tablet using a validated LC-MS/MS method. Bioequivalence was evaluated using the reference-scaled average bioequivalence (RSABE) approach when the within-subject standard deviation of the reference product (SWR) exceeded 0.29, while the average bioequivalence (ABE) method was applied for SWR values below 0.29. Pharmacokinetic profiles of two enteric-coated aspirin tablets were comparable after single-dose administration. The mean Tmax, Cmax, and AUC0-t were 5.5 h, 603.97 ng/mL and 786.47 h·ng/mL for acetylsalicylic acid, and 6.50 h, 4033.66 ng/mL, and 20,115.18 h·ng/mL for salicylic acid, respectively. Food delayed the Tmax and increased the Cmax but had no effect on the aspirin's overall exposure. 90% CI of geometric mean ratios (GMRs) of Cmax, AUC0-t, and AUC0-∞ of acetylsalicylic acid and salicylic acid of two enteric-coated aspirin tablets fell within the predefined bioequivalence range of 80.0-125.0% under both fasted and fed conditions. Safety assessments revealed that all treatments were safe and well tolerated. Two enteric-coated aspirin tablets were bioequivalent in Chinese healthy subjects under both fasted and fed condition. All treatments were well tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Affiliated Beijing Luhe Hospital of Capital Medical University, Beijing, 101149, P.R, China.
- Anesthesiology Class 211, First Clinical Medical College of Nanchang University, Nanchang, 330008, P.R, China.
- Nanjing Daoqun Pharmaceutical R & D Co., Ltd, Nanjing, 310024, P.R, China.
- Beijing Nuokangda Pharma Co., Ltd, Beijing, 100176, P.R, China.
- Department of Clinical Pharmacology, Affiliated Beijing Luhe Hospital of Capital Medical University, Beijing, 101149, P.R, China. medicalwangxh@outlook.com.
Zitieren
APA
Hu, M., Zhang, S., Xu, P., Li, J., Pang, H., Yang, M., Chen, F., Gao, B., & Wang, X. (2025). Pharmacokinetics, bioequivalence, and food effect assessment of enteric-coated aspirin tablets: a randomized, single-dose, four-period crossover study in Chinese healthy subjects. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04282-w
Vancouver
Hu M, Zhang S, Xu P, Li J, Pang H, Yang M, et al. Pharmacokinetics, bioequivalence, and food effect assessment of enteric-coated aspirin tablets: a randomized, single-dose, four-period crossover study in Chinese healthy subjects. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04282-w
BibTeX
@article{Hu2025,
author = {Hu, Minwan and Zhang, Shuyu and Xu, Peng and Li, Jiangfan and Pang, Hongxian and Yang, Man and Chen, Fangyu and Gao, Baoqing and Wang, Xuhong},
title = {Pharmacokinetics, bioequivalence, and food effect assessment of enteric-coated aspirin tablets: a randomized, single-dose, four-period crossover study in Chinese healthy subjects},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04282-w}
}
EUVIMED